Porcine genome engineering for xenotransplantation
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 168, 229-245
Abstract
No abstract availableKeywords
Funding Information
- R&D Fund of Zhejiang A&F University (2019FR022, 2019FR052)
- Fund from Nanjing Municiple Human Resources and Social Security Bureau
This publication has 257 references indexed in Scilit:
- Transgenic swine: Expression of human CD39 protects against myocardial injuryJournal of Molecular and Cellular Cardiology, 2012
- Efficient generation of a biallelic knockout in pigs using zinc-finger nucleasesProceedings of the National Academy of Sciences, 2011
- Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti‐nonGal IgG binding to porcine aortic endothelial cellsJournal of Thrombosis and Haemostasis, 2010
- Genome editing with engineered zinc finger nucleasesNature Reviews Genetics, 2010
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAsXenotransplantation, 2009
- Expression of Tissue Factor and Initiation of Clotting by Human Platelets and Monocytes After Incubation With Porcine Endothelial CellsTransplantation, 2008
- Recombinant pig TFPI efficiently regulates human tissue factor pathwaysXenotransplantation, 2008
- The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered SignalsImmunity, 2008
- Role for CD47-SIRPα signaling in xenograft rejection by macrophagesProceedings of the National Academy of Sciences, 2007